Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Operating Leases (2019 - 2025)

Jaguar Health (JAGX) has disclosed Operating Leases for 6 consecutive years, with $892000.0 as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 30.03% to $892000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $892000.0 through Dec 2025, up 30.03% year-over-year, with the annual reading at $892000.0 for FY2025, 30.03% up from the prior year.
  • Operating Leases for Q4 2025 was $892000.0 at Jaguar Health, down from $918000.0 in the prior quarter.
  • The five-year high for Operating Leases was $998000.0 in Q1 2025, with the low at $351000.0 in Q3 2023.
  • Average Operating Leases over 5 years is $797684.2, with a median of $868000.0 recorded in 2022.
  • The sharpest move saw Operating Leases plummeted 52.44% in 2023, then skyrocketed 114.81% in 2024.
  • Over 5 years, Operating Leases stood at $919000.0 in 2021, then decreased by 21.11% to $725000.0 in 2022, then increased by 22.21% to $886000.0 in 2023, then fell by 22.57% to $686000.0 in 2024, then skyrocketed by 30.03% to $892000.0 in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $892000.0, $918000.0, and $960000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.